BAIOCCHI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 1.597
EU - Europa 272
AS - Asia 198
AF - Africa 13
SA - Sud America 4
OC - Oceania 2
Totale 2.086
Nazione #
US - Stati Uniti d'America 1.570
IT - Italia 112
IN - India 78
SE - Svezia 71
CN - Cina 64
SG - Singapore 52
CA - Canada 25
GB - Regno Unito 20
UA - Ucraina 17
FI - Finlandia 15
DE - Germania 14
TG - Togo 12
RO - Romania 7
BG - Bulgaria 4
FR - Francia 4
IE - Irlanda 3
AR - Argentina 2
BE - Belgio 2
IR - Iran 2
MX - Messico 2
AU - Australia 1
BH - Bahrain 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 2.086
Città #
Fairfield 272
Houston 155
Ashburn 144
Woodbridge 138
Seattle 121
Cambridge 106
Wilmington 101
Chandler 88
Rome 57
Ann Arbor 52
Beijing 52
Princeton 40
Plano 33
Lawrence 31
Singapore 25
Boston 22
San Diego 21
Ottawa 18
San Paolo di Civitate 17
Andover 12
Lomé 12
Millbury 12
Dearborn 11
Falls Church 8
Norwalk 8
Mannheim 7
Helsinki 6
Toronto 6
Cagliari 5
Como 5
Phoenix 4
Sofia 4
Dublin 3
Fiesole 3
Fremont 3
Oxford 3
Rotherham 3
Atessa 2
Boardman 2
Brussels 2
Bühl 2
Des Moines 2
Dijon 2
Federal 2
Galdo 2
Guangzhou 2
Hefei 2
London 2
Mexico City 2
New York 2
Padula 2
Redwood City 2
San Mateo 2
Shenyang 2
Southend 2
Washington 2
Anaheim 1
Auburn Hills 1
Auckland 1
Baotou 1
Bern 1
Bologna 1
Bremen 1
Budapest 1
Buffalo 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Fasano 1
Gelsenkirchen 1
Indiana 1
Jacksonville 1
Jinan 1
Kunming 1
Las Vegas 1
Los Angeles 1
L’Aquila 1
Mercato San Severino 1
Milan 1
Montclair 1
Muizenberg 1
Nanjing 1
Napoli 1
Oakville 1
Palermo 1
Prime 1
Provo 1
Pune 1
Riva 1
Santa Clara 1
Santa Rosa 1
Springfield 1
Taipei 1
Waltham 1
Zhengzhou 1
Totale 1.685
Nome #
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents 163
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype 88
New models for cancer research: human cancer stem cell xenografts 84
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance 84
A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer 82
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34 +KDR+ cells 77
Dynamic regulation of the cancer stem cell compartment by cripto-1 in colorectal cancer 75
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 71
A novel high resolution, high sensitivity SPECT detector for molecular imaging of cardiovascular diseases 70
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors 70
The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues 69
A powerful readout system for high resolution and high efficiency molecular imaging studies of cardiovascular diseases in mice 64
Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines 64
Anti-HIV Viral Interference Induced by Retroviral Vectors Expressing a Nonproducer HIV-1 Variant 63
Colorectal cancer spheroid biobanks: multi-level approaches to drug sensitivity studies 60
5-azacytidine reactivates the erythroid differentiation potential of the myeloid-restricted murine cell line 32D Ro 58
Aspects of the biology of the neonatal hematopoietic stem cell 58
Circulating progenitor cells in human ontogenesis: response to growth factors and replating potential 58
Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface 57
Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells 54
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells 54
An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in human CD34+cells 53
Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis 53
How to assess drug resistance in cancer stem cells 51
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 51
LINE-1 retrotransposon copies are amplified during murine early embryo development 49
Isolation and biological characterization of two classes of blast-cell colony-forming cells from normal murine marrow 49
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XLinhibition in non-small cell lung cancer 45
Selective extraction of haemagglutinin and matrix protein from Sendai virions by employing trifluoperazine as a detergent 45
Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection 41
null 37
In utero. La scienza e i nuovi modi di diventare madre 30
Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7 26
Myogenic potential of mouse primordial germ cells 26
Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase 23
Simple purification and secondary structure evaluation of Sendai virus neuraminidase water soluble fragment 20
COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse? 19
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 19
Stem cell factor and the amplification of progenitor cells from CD34+ cord blood cells 13
Totale 2.173
Categoria #
all - tutte 6.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020588 0 22 13 31 61 82 91 80 74 61 41 32
2020/2021161 23 37 4 5 6 3 5 13 28 24 12 1
2021/2022390 5 23 40 18 71 11 14 40 23 25 39 81
2022/2023348 79 74 18 39 32 27 15 12 33 1 14 4
2023/2024190 17 31 8 17 32 22 1 7 1 21 15 18
2024/202512 7 5 0 0 0 0 0 0 0 0 0 0
Totale 2.173